The telehealth provider Hims & Hers delivered impressive third-quarter 2025 results on November 3, 2025, yet simultaneously announced an unexpected execu ...

Shares of Hims & Hers Health ($HIMS) rallied on Tuesday after management said it’s in discussions with Novo Nordisk ($NVO) to ...

Hims & Hers continues to sell compounded semaglutide, the active ingredient in Novo’s Wegovy and Ozempic drugs, and these ...

Hims and Hers Health beat Wall Street estimates for third-quarter revenue on Monday, as the telehealth company added ...

Less than six months after ending a short-lived partnership, US telehealth firm Hims & Hers (Nasdaq: HIMS) and Danish ...

This week, Hims & Hers’ (NYSE:HIMS) recent Super Bowl ad campaign was at least twice mentioned by Marty Makary, Commissioner of the U.S. Food and Drug Administration (FDA) as a glaring example of how ...

The telehealth provider Hims & Hers delivered a financial report for the quarter ending September 30th that presented ...

Aug 5 (Reuters) - Shares of Hims & Hers (HIMS.N), opens new tab fell nearly 9% on Tuesday after the telehealth firm reported weaker-than-expected quarterly revenue, in part as its move from branded to ...

Live Updates Get The Best Hims & Hers Live Earnings Coverage Like This Every Quarter Get earnings reminders, our top analysis on Hims & Hers, market updates, and brand-new stock recommendations ...

We recently published 10 Hot Stocks Sparking Buying Frenzy. Hims & Hers Health Inc. (NYSE:HIMS) is one of the best performers on Tuesday. Hims & Hers rallied for a second day on Tuesday, adding 5.86 ...

Casting two roles for a commercial campaign for HIMS, a men’s sexual health product. Looking to feature a couple (or two people playing a couple). The tone of the spot is subtle and honest, featuring ...

At a White House event Thursday, President Trump announced deals with drug makers Novo Nordisk and Eli Lilly to offer their ...